Ensysce Biosciences, Inc.: Ensysce Biosciences Announces the Distribution of Series A Preferred Stock to Holders of Its Common Stock
SAN DIEGO, CA / ACCESSWIRE / February 1, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry